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Abstract
The recent decline in the effectiveness of some azole fungicides in controlling the
wheat pathogenMycosphaerella graminicola has been associated with mutations in
the CYP51 gene encoding the azole target, the eburicol 14a-demethylase (CYP51),
an essential enzyme of the ergosterol biosynthesis pathway. In this study, analysis
of the sterol content of M. graminicola isolates carrying different variants of the
CYP51 gene has revealed quantitative differences in sterol intermediates, particu-
larly the CYP51 substrate eburicol. Together with CYP51 gene expression studies,
these data suggest that mutations in the CYP51 gene impact on the activity of the
CYP51 protein.
Introduction
Azole (imidazole and triazole) fungicides interrupt bio-
synthesis of ergosterol, an essential sterol of fungal cell
membranes, by inhibiting the cytochrome P450 eburicol
14a-demethylase (CYP51) (Yoshida & Aoyama, 1987). This
inhibition prevents demethylation of eburicol, the principal
CYP51 substrate in most filamentous fungi, resulting in a
depletion of ergosterol and a concomitant accumulation of
nonfunctional 14a-methyl sterols, including eburicol. The
accumulation of 14a-methyl sterols and the depletion of
ergosterol itself, perturbs membrane function and prevents
further fungal growth.
Azoles have been the leading agents for the control of
fungal pathogens of humans, animals and plants for over 30
years. Resistance to this class of chemistry is now common
in human pathogens, including Candida spp. (Kontoyiannis
& Lewis, 2002) and Aspergillus fumigatus (Warnock et al.,
1999), and is a serious problem in clinical antifungal
therapy. As a consequence, the molecular basis of azole
resistance is best understood in these pathogens. Common
mechanisms of azole resistance in Candida albicans are
alteration of the CYP51 target protein (Sanglard et al.,
1998; Marichal et al., 1999) and enhanced efflux of azole
outside the cell mediated by the over expression of energy-
dependent efflux proteins (Sanglard et al., 1995; Perea et al.,
2001). Altered ergosterol biosynthesis, although a less com-
mon mechanism of azole resistance, has been reported for
C. albicans (Nolte et al., 1997). These isolates, cross resistant
to fluconazole and amphotericin B, have reduced levels of
ergosterol and accumulate sterols lacking a C5(6) double
bond, a result of null mutations in the gene (erg3) encoding
the sterol C5(6) desaturase (Kelly et al., 1995, 1996). How-
ever, these isolates grew poorly in vivo (Nolte et al., 1997),
probably as a result of using 14a-methylated sterols rather
than ergosterol in cell membrane synthesis.
Azole resistance in plant pathogens has developed more
slowly, and rarely leads to a loss of field efficacy. Recently,
FEMS Microbiol Lett 296 (2009) 266–273c 2009 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
D
ow
nloaded from
 https://academ
ic.oup.com
/fem
sle/article-abstract/296/2/266/604995 by Periodicals Assistant - Library user on 23 D
ecem
ber 2019
however, there has been a notable decline in the effectiveness
of a number of azoles in controllingMycosphaerella gramini-
cola so that some compounds no longer control the disease
(Clark, 2006). This fungus causes Septoria leaf blotch, the
most economically important foliar disease of winter wheat
in North West Europe. Studies suggest alterations in the
target protein, caused by mutations in the CYP51 gene, are
responsible for this recent decline in sensitivity in M.
graminicola populations (Cools & Fraaije, 2008). Some
CYP51 substitutions identified in M. graminicola isolates,
less sensitive to azoles, are at equivalent residues to those
found in resistant strains of C. albicans, for example Y137F
(Cools et al., 2005; Leroux et al., 2007), whereas others,
including V136A (Leroux et al., 2007), A379G (Leroux et al.,
2007) and I381V (Cools et al., 2005; Fraaije et al., 2007;
Leroux et al., 2007) are unique toM. graminicola.
While studies have demonstrated clear correlations be-
tween CYP51 alterations and altered azole sensitivity in M.
graminicola (Fraaije et al., 2007; Leroux et al., 2007), the
effects of these changes on azole affinity or CYP51 activity
have yet to be elucidated. In this study, we established the
impact of alterations in the CYP51 protein ofM. graminicola
on sterol biosynthesis by analysing the sterol content of M.
graminicola field isolates carrying different variants of the
CYP51 gene.
Materials and methods
Culturing of M. graminicola isolates
Isolates (Table 1) were grown in triplicate on yeast peptone
dextrose (YPD) agar (ForMedium, Norwich, UK) at 15 1C
for 7 days. Spores from each culture were harvested and
diluted to a concentration of 4.5 105 sporesmL1 in
100mL YPD broth (ForMedium) and incubated for 72 h at
21 1C, with shaking at 220 r.p.m. Replicate fungal cultures
were collected by vacuum filtration through 8-mM pore
nitrocellulose filters (Millipore, Billerica), snap frozen in
liquid nitrogen and freeze dried before free sterol and RNA
extractions.
Azole sensitivity testing
Sensitivity assays were modified from Fraaije et al. (2007). A
100-mL aliquot of 2 potato dextrose broth (PDB; Sigma-
Aldrich Inc., St. Louis) amended with decreasing concentra-
tions of epoxiconazole (50, 16.7, 5.6, 1.9, 0.62, 0.21, 0.069,
0.023, 0.008, 0.0025 and 0.0008mgL1), tebuconazole (50, 20,
8, 3.2, 1.3, 0.51, 0.2, 0.082, 0.033, 0.013 and 0.0052mgL1) or
prochloraz (10, 3.3, 1.1, 0.37, 0.12, 0.041, 0.014, 0.0046,
0.0015, 0.0005 and 0.00017mgL1) was added to wells of
flat-bottomed microtitre plates (TPP 92696 test plates, Trasa-
dingen, Switzerland). After 7 days of growth at 15 1C on YPD
to ensure yeast-like growth, isolates were suspended in 5mL
of sterile distilled water. Aliquots of 100mL of isolate spore
suspensions (1 105 sporesmL1) were added to each well.
Plates were incubated for 4 days at 23 1C, and growth
measured at A630nm using a Fluorstar Optima microplate
reader (BMG Labtech GmbH, Offenberg, Germany). Fungi-
cide sensitivities were determined as 50% effective concentra-
tion (EC50) using a dose–response relationship.
CYP51 sequencing
CYP51 genes of M. graminicola isolates IPO323, Berdun 17,
R6-31, Berdun 13, Berdun 10, Berdun 4, V103.9, V115.3,
V209.10, V209.9, V212.2, V214.7 and V202.1 (Table 1; NCBI
GenBank accessions: FJ196446–FJ196457) were amplified
and sequenced using primers, PCR conditions and protocols
Table 1. Isolates of Mycosphaerella graminicola used for sterol content analysis
Isolate designation Location and year of isolation
Mean EC50 (mg L
1)
CYP51 alteration(s)Epoxiconazole Tebuconazole Prochloraz
IPO323 North Brabant, the Netherlands; 1981 0.071 0.491 0.382 None (wild type)
Berdun 17 Aragon, Spain; 2006 0.066 0.319 0.097 None (wild type)
R6-31 Hertfordshire, UK; 2006 0.958 1.36 1.86 Y137F
Berdun 13 Aragon, Spain; 2006 ND ND ND Y137F
Berdun 10 Aragon, Spain; 2006 0.081 0.273 0.121 L50S
Berdun 4 Aragon, Spain; 2006 0.121 0.562 0.293 G460D
V103.9 Kent, UK; 2006 1.26 0.492 2.19 L50S, V136A, Y461H
V115.3 Kent, UK; 2006 0.817 4.12 0.704 L50S, I381V, Y461H
V209.10 Kent, UK; 2006 1.825 5.99 0.657 L50S, I381V, Y461H
V209.9 Kent, UK; 2006 0.735 0.712 2.48 V136A, S188N, DY459/G460
V212.2 Kent, UK; 2006 1.28 4.41 2.58 V136A, S188N, DY459/G460
V214.7 Kent, UK; 2006 1.66 9.17 0.107 L50S, S188N, A379G, I381V, DY459/G460, N513K
V202.1 Kent, UK; 2006 1.05 10.1 0.104 L50S, S188N, A379G, I381V, DY459/G460, N513K
Based on predicted protein sequence for isolate ST1 (accession number AY730587).
ND, not determined.
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outlined in Cools et al. (2005). Amplifications were carried
out using Phusion high-fidelity DNA polymerase to ensure
the validity of sequences (Finnzymes, Espoo, Finland).
Total sterol extraction and derivatization
Sterol extraction and analysis was adapted from Hey et al.
(2006). Fifty milligrams of lyophilized tissue from each
biological replicate was extracted with 5mL of 2 : 1 (v/v)
chloroform :methanol containing 50mg dihydrocholesterol
(internal standard) at 55 1C, for 30min. The cooled mixture
was filtered and the solvent removed under a stream of
gaseous nitrogen. To the lipid residue obtained, 1mL toluene
and 2mL sodium methoxide (0.5M) in methanol were
added and the sample heated at 60 1C for 30min. Once
cooled, 2mL of 14% boron trifluoride in methanol was
added and the sample heated at 60 1C for a further 10min.
Once cooled, 2–3mL diethyl ether and 5mL deionized water
were added. The ether layer was removed to a clean vial and
the aqueous phase re-extracted with a further 2–3mL diethyl
ether and both extracts combined. After backwashing with
5mLwater, the organic phase was then dried, overnight, over
anhydrous sodium sulphate and filtered through glass wool.
The filtrate was collected in a fresh vial and the solvent was
removed under a stream of gaseous nitrogen. The dry residue
was resuspended in 300mL toluene and silylated with 200mL
N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) at
50 1C for 10min. All samples (isolates/treatment combina-
tions) were prepared and analysed in triplicate. Reagents
were obtained from Sigma-Aldrich (Gillingham, Dorset,
UK) unless otherwise stated.
GC-MS analysis
GC-MS analysis was carried out on a Hewlett Packard (Palo
Alto, CA) 5890 Series Gas Chromatograph coupled to a 5970
Series Mass Selective Detector and fitted with 7373 automatic
liquid sampler and Zebron ZB5 column with 5m Guardian
(Phenomenex, Macclesfield, UK; 30m 0.25mm internal
diameter 0.25mm film). One-microlitre splitless injections
were given at an inlet temperature of 280 1C and 105 kPa head
pressure. The oven was set to an initial temperature of 100 1C
for 2min), then ramped at 10 1Cmin1 to 320 1C and held for
6min. The GC interface was 290 1C and electron ioniza-
tion1mass spectra, 41–750 amu, were acquired from 13 to
30min, with the threshold set to 150 and a 1.15 scan s1 scan
rate. Data analysis was conducted in the QuanLynx module of
MassLynx (Waters, Manchester, UK), following conversion of
the data files from their native (HP) format to Masslynx files
using the MASS TRANSIT file conversion utility program (Pali-
sade, Newfield, NY). Peak areas were normalized to the
internal standard.
To eliminate the contribution from coeluting hydrocar-
bons, reconstituted total ion chromatogram (TIC) peak
areas were calculated by dividing the integrated extracted
ion chromatogram peak areas of individual sterols by the
quantification of the ion’s contribution to the TIC, allowing
direct comparison of the relative concentrations, within and
between samples, to be made (equal reconstituted peak areas
representing approximately equal concentrations).
For ergosterol, lanosterol, cholesterol and dihydrocholes-
terol, identifications were confirmed using authentic stan-
dards. For all other sterols, putative identifications were
made on the basis of literature relative retention times
combined with matching the experimentally obtained spec-
tra to those in the National Institute of Standards and
Technology (NIST) Spectral Library.
CYP51 expression
Levels of CYP51 transcript were measured with real-time
reverse transcription (RT)-PCR. Roughly 30-mg powdered
freeze dried fungal material from each biological replicate
was placed in a 2-mL screw top tube with a 3mm stainless
steel ball and run through a FastPrep shaker at 4.5ms1 for
30 s (FP120, Bio101/Savant, MPBiomedicals). One millilitre
of TRIZOL reagent (Invitrogen, Paisley, UK) was then added
and run through the FastPrep once again. TRIZOLwas used
according to the manufacturer’s protocol, and further RNA
purification was achieved with an overnight 4-M lithium
chloride precipitation.
Reverse transcription of the first strand of cDNA was
carried out with the Superscript III RT-PCR kit (Invitrogen)
following the manufacturer’s protocol using oligo d(T)
primers and 5 mg total RNA per reaction. A one in 10
dilution of this reaction was used as the template for the
real-time PCR analysis.
Real-time PCR reactions were carried out with Platinum
SYBR green PCRmix with ROX (Invitrogen) and a modified
version of the supplier’s protocol, using 5 mL cDNA solution
in a 25-mL reaction and CYP51-specific primers from Cools
et al. (2007). The cycling conditions used were 50 1C for
2min, 95 1C for 2min, and then 40 replicates of 95 1C for
15 s, 58 1C for 30 s and 72 1C for 36 s. Each reaction was
carried out in triplicate, in the ABI PRISM 7500 sequence
detection system (Applied Biosystems, Foster City, CA).
Relative quantification values were calculated with the
2DDCt method using the constitutively expressed house-
keeping b-tubulin gene as an endogenous control, and gene
expression levels in the ‘wild-type’ isolate IPO323 untreated
sample were used as calibrators. Transcript abundance was
measured in triplicate for each isolate.
Statistical analysis
A linear model and ANOVA were used to estimate the effect of
each amino acid alteration on the relative efficiency of the
demethylation step calculated as the logarithm of the
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product of eburicol content (E) and CYP51 transcript
abundance (C). Not all combinations of alterations were
present. Therefore, it was possible to ascribe the variation in
calculated enzyme efficiency to alterations in more than one
way. The regression fit provided by all subsets of the
mutations was used to determine economical descriptions
of the data by effects of individual mutations. Model
selection took into account Mallow’s Cp, the proportion of
the variance accounted for by the model and F-tests of the
effect of deleting a factor from the model. Calculations were
performed in GENSTAT v10 (VSN International, Oxford).
Results
Isolate azole sensitivities
Correlations between azole sensitivities and CYP51 altera-
tions were consistent with previous studies (Cools et al.,
2005; Fraaije et al., 2007; Leroux et al., 2007). Isolates
carrying substitution I381V were resistant to tebuconazole
and considered sensitive to prochloraz, whereas isolates
carrying substitution V136A were resistant to prochloraz
and, with the exception of V212.2, more sensitive than
isolates carrying I381V to tebuconazole. EC50 values for
isolate R6-31, carrying substitution Y137F, were higher to all
azoles than for wild-type isolates or those carrying L50S or
G460D alone (Table 1).
Identification of sterols
Ergosterol, lanosterol, cholesterol and dihydrocholesterol
were identified with authentic standards. Ergosta-7,22-die-
nol, fungisterol, epiergosterol, 4,4-dimethylfecosterol and
eburicol were identified according to the retention time
and mass spectra data published or present in the NIST MS
database (Table 2). However, due to lack of comparisons,
other sterols could not be identified with certainty. These are
designated as unknown sterols. It was possible to identify
unknown sterols 1 and 2 as desmethyl sterols through MS
(data not shown). Mass spectra of ergosterol and its stereo-
isomer have closely related fragmentation therefore the
stereochemistry of the isomer is unknown. Studies by
Joseph-Horne et al. (1996) of M. graminicola predicted the
isomer to have an a-hydroxy moiety at C-3 rather than the
usual b-hydroxy, and as no further evidence can be pre-
sented here, the same tentative designation is maintained.
Sterol content related to CYP51 sequence
Quantitative differences in the level of different sterols were
detected, particularly eburicol levels, although these could
not be directly related to predicted CYP51 amino acid
sequence. There were no significant differences in ergosterol
content between isolates (P= 0.05), suggesting that all iso-
lates are able to produce functional levels of ergosterol in
vitro (Table 3).
There were no differences in the type of sterols present,
suggesting that sterol biosynthesis is similar in each of these
isolates (Table 3). As in earlier studies by Joseph-Horne et al.
(1996), 14a-methylfecosterol or 14a-methyl-3,6-diol were
not detected in any isolate.
CYP51 expression and relationship with
eburicol content
Expression of CYP51 was analysed from the same samples as
sterol content. CYP51 transcript was detected in all isolates,
with the lowest level in IPO323 to which relative expression
in all other isolates was calibrated. The highest levels of
CYP51 transcript were detected in isolates V103.9 and
Table 2. Designation of sterols by relative retention times and authentic samples
GC peak Retention time RRt Moretti et al. (2003) RRt Loeffler & Hayes (1990) RRt Barrero et al. (1998) Designation
1 24.89 – – – Unknown 1
2 25.21 – – 1 Cholesterolw
3 25.32 1 1 – Dihydrocholesterolw,z
4 25.68 – – – Ergosterol isomer
5 25.91 – – – Nonsterol
6 25.98 1.19 1.096 1.12 Ergosterolw
7 26.12 1.23 1.117 1.155 Ergosta-7,22-dienol
8 26.49 1.31 – – Unknown 2
9 26.61 – 1.184 1.25 Episterol
10 26.68 1.38 – 1.259 Fungisterol
11 26.92 – – 1.298 Lanosterolw
12 27.57 1.62 1.313 1.422 Eburicol
R2 0.9991 0.9993 0.9962
RRt, relative retention time of the TMS derivative with respect to the TMS-ether of dihydrocholesterol or cholesterol.
wIdentified with authentic sample.
zDihydrocholesterol (containing low levels of cholesterol) used as surrogate standard.
FEMS Microbiol Lett 296 (2009) 266–273 c 2009 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
269Sterol content analysis of M. graminicola
D
ow
nloaded from
 https://academ
ic.oup.com
/fem
sle/article-abstract/296/2/266/604995 by Periodicals Assistant - Library user on 23 D
ecem
ber 2019
Ta
b
le
3
.
St
er
o
lc
o
n
te
n
t
o
f
M
yc
o
sp
h
ae
re
lla
g
ra
m
in
ic
o
la
is
o
la
te
s
St
er
o
ls

SE
(n
=
3
)
Is
o
la
te
st
er
o
lc
o
n
te
n
t
(m
g
g
1
)
B
er
d
u
n
1
7
IP
O
3
2
3
B
er
d
u
n
1
0
B
er
d
u
n
4
B
er
d
u
n
1
3
R
6
-3
1
V
1
0
3
.9
V
1
1
5
.3
V
2
0
9
.1
0
V
2
0
9
.9
V
2
1
2
.2
V
2
0
2
.1
V
2
1
4
.7
U
n
kn
o
w
n
st
er
o
l1
0
.0
1
8
0
.0
4
2

0
.0
2
9
0
.0
1
6
0
.0
4
6

0
.0
1
9
0
.0
1
9
0
.0
2
3
0
.0
1
7
0
.0
1
8
0
.0
1
9
0
.0
1
8
0
.0
1
5
5
.1
E

0
3
1
.7
E

0
3
2
.5
E

0
3
2
.8
E

0
3
5
.2
E

0
3
5
.9
E

0
3
4
.1
E

0
3
6
.3
E

0
3
3
.5
E

0
3
6
.5
E

0
3
5
.1
E

0
3
3
.6
E

0
3
1
.7
E

0
3
C
h
o
le
st
er
o
lw
0
.0
1
5
0
.0
1
6
0
.0
1
3
0
.0
1
6
0
.0
0
5

0
.0
1
7
0
.0
1
4
0
.0
1
5
0
.0
1
6
0
.0
1
5
0
.0
1
5
0
.0
1
5
0
.0
1
6
2
.1
E

0
3
2
.8
E

0
3
1
.8
E

0
4
7
.7
E

0
4
4
.8
E

0
3
1
.6
E

0
3
6
.1
E

0
4
5
.5
E

0
4
6
.2
E

0
4
4
.8
E

0
4
1
.2
E

0
3
6
.5
E

0
4
9
.9
E

0
4
Er
g
o
st
er
o
li
so
m
er
1
.1
5
2

0
.8
8
3
0
.9
1
9
1
.2
0
5

0
.9
9
7
0
.8
1
9
0
.6
6
7

0
.8
9
3
0
.7
8
5
0
.8
4
4
0
.7
7
8
0
.8
5
6
0
.9
3
0
.0
3
2
0
.0
3
4
0
.0
4
8
0
.0
4
2
0
.0
9
7
0
.0
3
7
0
.0
8
3
0
.0
8
2
0
.1
1
6
0
.0
5
4
0
.0
6
8
0
.0
8
6
0
.0
9
3
Er
g
o
st
er
o
l
1
.1
0
5
1
.0
0
7
0
.9
2
9
1
.0
5
6
1
.0
1
2
0
.9
5
5
0
.7
8
4
1
.0
4
7
0
.8
1
9
0
.9
3
4
1
.0
1
1
.1
0
7
0
.8
8
1
0
.0
5
0
0
.0
6
1
0
.0
4
8
0
.0
1
2
0
.1
1
3
0
.0
6
7
0
.1
2
6
0
.1
4
2
0
.1
1
1
0
.0
9
1
0
.0
7
9
0
.0
8
3
0
.1
1
1
Er
g
o
st
a-
7
,2
2
-d
ie
n
o
l
0
.0
9
6
0
.0
9
0
.0
7
8
0
.0
8
4
0
.0
6
6
0
.1
1
6

0
.0
4
9
0
.0
7
4
0
.1
0
9
0
.0
4
8
0
.0
5
3
0
.0
4
9
0
.0
8
9
2
.2
E

0
3
5
.8
E

0
3
6
.1
E

0
3
6
.8
E

0
3
7
.9
E

0
3
9
.1
E

0
3
6
.3
E

0
3
9
.1
E

0
3
0
.0
2
9
6
.3
E

0
3
6
.9
E

0
3
9
.0
E

0
3
0
.0
1
6
U
n
kn
o
w
n
st
er
o
l2
0
.0
4
7

0
.0
4
1
0
.0
2
9
0
.0
5
0

0
.0
3
2
0
.0
2
0

0
.0
2
0
.0
2
9
0
.0
2
4
0
.0
1
8

0
.0
2
3
0
.0
5
1

0
.0
3
3
1
.9
E

0
3
1
.8
E

0
3
9
.4
E

0
4
4
.4
E

0
3
5
.4
E

0
3
2
.7
E

0
3
5
.5
E

0
3
4
.5
E

0
3
3
.7
E

0
3
2
.6
E

0
3
2
.2
E

0
3
8
.3
E

0
3
6
.8
E

0
3
Ep
is
te
ro
l
0
.2
8
8

0
.1
7
2
0
.2
2
3

0
.2
6
4

0
.1
6
8
0
.0
9
4
0
.0
1
1

0
.2
6
4

0
.2
1
0
.0
3
8

0
.0
5
0

0
.0
7
4

0
.1
5
5
0
.0
2
2
3
.0
E

0
3
0
.0
1
1
0
.0
1
6
0
.0
2
1
6
.7
E

0
3
2
.4
E

0
3
0
.0
2
1
0
.0
6
6
9
.3
E

0
3
7
.3
E

0
3
0
.0
1
1
0
.0
1
8
Fu
n
g
is
te
ro
l
0
.1
1
7
0
.1
1
1
0
.1
2
0
.1
0
.0
9
4
0
.0
6
0
.0
1
4

0
.1
2
1

0
.1
0
4
0
.0
2
7

0
.0
2
6

0
.0
4
9
0
.0
9
3
0
.0
1
0
4
.3
E

0
3
0
.0
1
0
7
.8
E

0
3
8
.2
E

0
3
3
.2
E

0
3
1
.4
E

0
3
0
.0
1
1
0
.0
2
9
2
.8
E

0
3
2
.3
E

0
3
7
.9
E

0
3
0
.0
1
2
La
n
o
st
er
o
l
4
.2
2
E

0
3
0
.1
1
6
1
.5
0
E

0
3
0
.0
0
3
0
.1
5
7

0
.0
0
6
0
.0
2
8
0
.1
4
8

0
.1
3

0
.0
2
8
0
.0
3
3
0
.0
2
0
.0
0
3
4
.4
E

0
4
0
.0
1
1
7
.8
E

0
4
4
.8
E

0
4
0
.0
3
4
1
.8
E

0
3
7
.9
E

0
3
0
.0
8
8
0
.0
3
9
9
.2
E

0
3
9
.6
E

0
3
4
.1
E

0
3
2
.7
E

0
4
Eb
u
ri
co
l
3
.5
0
E

0
3
0
.0
3
4
0
.0
0
4
0
.0
4
2
0
.2
5
6
0
.0
6
7
0
.0
7
9
0
.1
9
5
0
.0
3
6
0
.1
4
9
0
.2
7
8
0
.0
6
0
.0
1
7
4
.3
E

0
4
2
.2
E

0
3
6
.5
E

0
4
0
.0
1
2
0
.0
2
1
0
.0
2
2
0
.0
2
9
0
.1
2
0
0
.0
1
3
0
.0
4
4
0
.1
9
4
4
.2
E

0
3
1
.8
E

0
3
 S
ig
n
ifi
ca
n
tl
y
d
if
fe
re
n
t
fr
o
m
th
e
m
ea
n
o
f
al
li
so
la
te
s
(P
o
0
.0
5
).
w D
ih
yd
ro
ch
o
le
st
er
o
lu
se
d
as
su
rr
o
g
at
e
st
an
d
ar
d
,
in
w
h
ic
h
ch
o
le
st
er
o
lo
cc
u
rs
in
lo
w
q
u
an
ti
ti
es
.
FEMS Microbiol Lett 296 (2009) 266–273c 2009 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
270 T.P. Bean et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/fem
sle/article-abstract/296/2/266/604995 by Periodicals Assistant - Library user on 23 D
ecem
ber 2019
V209.9 (Table 4). CYP51 expression levels could not be
directly linked to eburicol levels (Table 4).
Mycosphaerella graminicola isolates grouped according to
their CYP51 variant efficiency 1/C E (where C=CYP51
expression, E= eburicol content). Highest values were ob-
tained for the wild-type isolates Berdun 17 and IPO323, and
isolates carrying single alterations L50S (Berdun 10) and
G460D (Berdun 4). Lowest values were obtained for isolates
carrying the CYP51 alteration, V136A (isolates V103.9,
V209.9 and V212.2), which had high levels of both CYP51
gene expression and eburicol content (Table 4). SE of CYP51
expressionwas large in two of the isolates (V103.9 and Berdun
17), but this did not affect the overall 1/C E classifications.
Statistical analysis of the impact of
CYP51 alterations
Three alterations I381V, V136A and Y137F together ex-
plained 44% of the variation in the log of eburicol content
significant at P= 0.08, 0.01 and 0.03, respectively. I381Vand
V136A together explained 61% of the variation in log
transcript abundance, with individual significance at
P= 0.07 and 0.002. Y137F, I381V and V136A also accounted
for 89.3% of the variance for 1/C E data. All three terms
were significant at Po 0.001 if dropped individually from
the model, indicating that changes in eburicol demethyla-
tion efficiency are mainly due to these substitutions. There
was no statistical evidence that any of the alterations present
compensate for one another. No nonadditive effects of
protein alterations on this efficiency measure were observed.
Discussion
Total lipid extraction and derivatization followed by GC-MS
was used to analyse the sterol content of M. graminicola
isolates carrying different variants of the CYP51 gene
predicted to encode amino acid alterations associated with
altered azole sensitivity. Previous experiments (data not
shown) had shown a significant increase in eburicol, the
substrate of CYP51, in isolates treated with azole, confirm-
ing that azole fungicides inhibit eburicol demethylation in
M. graminicola.
It was hypothesized that CYP51 changes may affect
intrinsic enzyme activity, resulting in eburicol accumula-
tion. The sterol content of 13 M. graminicola isolates with a
total of eight different combinations of CYP51 alterations
was analysed. Quantitative variations in sterol content
between isolates were detected, but their differences did not
appear to be related to CYP51 amino acid sequence.
Specifically, increased eburicol content could not be directly
correlated with CYP51 alterations and there was as much
variation in eburicol content between isolates carrying the
same CYP51 variant as between isolates with different
CYP51s. Azole resistance can be caused by CYP51 over-
expression, the most notable case being in azole-resistant
Penicillium digitatum isolates, which constitutively over-
expressed CYP51 100-fold (Hamamoto et al., 2000). How-
ever, in this study, the observed variation in CYP51
expression was considerably lower and could not be directly
correlated with either azole sensitivity or CYP51 sequence,
evidence that CYP51 sequence, not expression level, is the
most important factor in determining azole resistance in M.
graminicola.
Using a measurement of eburicol demethylation effi-
ciency, based on a combined measure of CYP51 expression
levels and eburicol content (1/C E), isolates with the same
CYP51 grouped together. Furthermore, statistical analyses
revealed CYP51 substitution V136A had the largest effect on
the measure of efficiency, with substantial effects also
Table 4. Grouping of Mycosphaerella graminicola isolates according to the CYP51 efficiency measure, 1/C E
Isolates CYP51 alterations Eburicol content (mg g1) CYP51 expressionw 1/C E
Berdun 17 None 3.50E 03 2.59 ( 2.75) 110.23
IPO323 None 0.034 1 ( 0.10) 29.02
Berdun 10 L50S 4.30E 03 3.54 ( 0.71) 65.61
Berdun 4 G460D 0.042 1.48 ( 0.23) 16.21
Berdun 13 Y137F 0.256 1.34 ( 0.58) 2.91
R6-31 Y137F 0.067 5.12 ( 0.84) 2.93
V115.3 L50S, I381V, Y461H 0.195 4.37 ( 0.96) 1.17
V209.10 L50S, I381V, Y461H 0.036 15.71 ( 3.33) 1.77
V202.1 L50S, S188N, A379G, I381V, DY459/G460, N513K 0.06 6.78 ( 2.80) 2.46
V214.7 L50S, S188N, A379G, I381V, DY459/G460, N513K 0.017 15.08 ( 2.01) 3.91
V103.9 L50S, V136A, Y461H 0.079 23.07 ( 12.53) 0.55
V209.9 V136A, S188N, DY459/G460 0.149 26.2 ( 8.15) 0.26
V212.2 V136A, S188N, DY459/G460 0.278 5.84 ( 0.57) 0.62
Milligrams of sterol per gram fungal biomass.
wRelative to IPO323 untreated.
C, CYP51 expression; E, eburicol content;  , SE (n= 3).
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produced by I381V and Y137F. Those variants with sub-
stitutions L50S and G460D appear to encode proteins with
unaltered efficiency. This is consistent with the impact of
these amino acid changes on azole sensitivity and the
location of these alterations in the predicted protein (Cools
& Fraaije, 2008). Although these data do not clarify the
effects of the CYP51 alterations on the biochemical proper-
ties of the enzyme, they clearly indicate that changes in
activity have occurred. 1/C E also suggests that the accu-
mulation of eburicol, caused by reduced enzyme activity,
can be accommodated by increased gene expression.
It is possible that CYP51 amino acid alterations selected
by azole treatment are reducing the intrinsic activity of
CYP51 particularly as accumulated eburicol does not appear
to be converted to the toxic sterol intermediate 14a-methyl-
3,6-diol in M. graminicola. Studies of Ustilago maydis, also
detected higher levels of 14a-methylated sterols, including
eburicol, in isolates with reduced azole sensitivity with
normal levels of ergosterol, suggesting leaky CYP51 activity
(Joseph-Horne et al., 1995). Further studies are underway to
determine the precise impact of individual CYP51 amino
acid alterations on intrinsic enzyme activity and azole
binding.
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